Oculus Innovative Sciences, Inc. (Nasdaq:OCLS), a biopharmaceutical company that develops, manufactures and markets a family of products based upon the Microcyn(R) Technology platform, which is intended to help prevent and treat infections in chronic and acute wounds, announced today that the company's research and development team has completed work on the development of a Microcyn hydrogel ...
By the time you're done with this area you should accept a acceptable abstraction of the science abaft abscess and feel assured in how you would like to proceed.
Wednesday, June 18, 2008
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment